BIND_score v.0.1.0
The BIND score (Bilirubin-Induced Neurologic Dysfunction score) is a clinical tool used to assess the severity of acute bilirubin toxicity in newborns, particularly in cases of kernicterus. It evaluates the neurological effects of severe hyperbilirubinemia by scoring three key domains, mental status, muscle tone, and cry pattern. The BIND score helps clinicians assess the need for urgent interventions like phototherapy or exchange transfusion to prevent long-term complications such as cerebral palsy or hearing loss.
To calculate and interpret the total sum for the BIND score
Used for neonates. Each category is scored from 0 to 3. A total score of 0 indicates no acute bilirubin encephalopathy (ABE), while a score between 1 and 3 suggests mild ABE. Scores ranging from 4 to 6 indicate moderate ABE, and a score between 7 and 9 represents severe ABE.
Not to be used for calculating or interpreting the modified BIND score.
Johnson LH, Brown AK, Bhutani VK. BIND - a clinical score for bilirubin-induced neurologic dysfunction in newborns. Pediatrics. 1999;199(3 part 3):746–7. El Houchi SZ, Iskander I, Gamaleldin R, El Shenawy A, Seoud I, Abou-Youssef H, Wennberg RP. Prediction of 3- to 5-Month Outcomes from Signs of Acute Bilirubin Toxicity in Newborn Infants. J Pediatr. 2017 Apr;183:51-55.e1. doi: 10.1016/j.jpeds.2016.12.079. Epub 2017 Jan 25. PMID: 28131490.
openEHR-EHR-OBSERVATION.bind, openEHR-EHR-EVALUATION.bind_score_assessment
